Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis

被引:352
|
作者
Janco, Jo Marie Tran [1 ]
Lamichhane, Purushottam [2 ,3 ]
Karyampudi, Lavakumar [3 ]
Knutson, Keith L. [2 ,3 ]
机构
[1] Mayo Clin, Div Gynecol Surg, Rochester, MN 55906 USA
[2] Mayo Clin, Dept Immunol, Rochester, MN 55906 USA
[3] Vaccine & Gene Therapy Inst, Canc Vaccines & Immune Therapies Program, Port St Lucie, FL 34987 USA
来源
JOURNAL OF IMMUNOLOGY | 2015年 / 194卷 / 07期
基金
美国国家卫生研究院;
关键词
REGULATORY T-CELLS; HUMAN COLORECTAL-CANCER; NATURAL-KILLER-CELLS; OVARIAN-CANCER; ANTITUMOR IMMUNITY; SUPPRESSOR-CELLS; IN-VIVO; ANTI-PD-1; ANTIBODY; GASTRIC-CANCER; MYELOID CELLS;
D O I
10.4049/jimmunol.1403134
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) play a pivotal role in the tumor microenvironment, which is known to affect disease progression in many human malignancies. Infiltration by mature, active DCs into the tumors confers an increase in immune activation and recruitment of disease-fighting immune effector cells and pathways. DCs are the preferential target of infiltrating T cells. However, tumor cells have means of suppressing DC function or of altering the tumor microenvironment in such a way that immune-suppressive DCs are recruited. Advances in understanding these changes have led to promising developments in cancer-therapeutic strategies targeting tumor-infiltrating DCs to subdue their immunosuppressive functions and enhance their immunestimulatory capacity.
引用
收藏
页码:2985 / 2991
页数:7
相关论文
共 50 条
  • [31] Tumor-Infiltrating Natural Killer Cells
    Cozar, Beatriz
    Greppi, Marco
    Carpentier, Sabrina
    Narni-Mancinelli, Emilie
    Chiossone, Laura
    Vivier, Eric
    CANCER DISCOVERY, 2021, 11 (01) : 34 - 44
  • [32] Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
    Krempski, James
    Karyampudi, Lavakumar
    Behrens, Marshall D.
    Erskine, Courtney L.
    Hartmann, Lynn
    Dong, Haidong
    Goode, Ellen L.
    Kalli, Kimberly R.
    Knutson, Keith L.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (12): : 6905 - 6913
  • [33] RANKL blockade inhibits cancer growth through reversing the tolerogenic profile of tumor-infiltrating (plasmacytoid) dendritic cells
    Pilard, Charlotte
    Roncarati, Patrick
    Ancion, Marie
    Luyckx, Margaux
    Renard, Michael
    Reynders, Celia
    Lerho, Thomas
    Poulain, Florian
    Bruyere, Diane
    Lebeau, Alizee
    Hendrick, Elodie
    Crake, Rebekah
    Peiffer, Raphael
    Nokin, Marie-Julie
    Peulen, Olivier
    Delvenne, Philippe
    Hubert, Pascale
    Herfs, Michael
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (03)
  • [34] Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer: Their relationship to KRAS mutational status and disease recurrence
    Kocian, Petr
    Sedivcova, Monika
    Drgac, Jan
    Cerna, Katerina
    Hoch, Jiri
    Kodet, Roman
    Bartunkova, Jirina
    Spisek, Radek
    Fialova, Anna
    HUMAN IMMUNOLOGY, 2011, 72 (11) : 1022 - 1028
  • [35] Correlation of vascular endothelial growth factor-C expression with tumor-infiltrating dendritic cells in gastric cancer
    Takahashi, A
    Kono, K
    Itakura, J
    Amemiya, H
    Tang, RF
    Iizuka, H
    Fujii, H
    Matsumoto, Y
    ONCOLOGY, 2002, 62 (02) : 121 - 127
  • [36] Clinical significance of tumor-infiltrating conventional and plasmacytoid dendritic cells in pancreatic ductal adenocarcinoma
    Plesca, Ioana
    Benesova, Iva
    Beer, Carolin
    Sommer, Ulrich
    Mueller, Luise
    Wehner, Rebekka
    Heiduk, Max
    Aust, Daniela
    Baretton, Gustavo
    Bachmann, Michael P.
    Feldmann, Anja
    Weitz, Juergen
    Seifert, Lena
    Seifert, Adrian M.
    Schmitz, Marc
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 76 - 76
  • [37] Tumor-Infiltrating Dendritic Cells May Be Used as Clinicopathologic Prognostic Factors in Endometrial Carcinoma
    Zhao Lijun
    Zhao Xin
    Shen Danhua
    Li Xiaoping
    Wang Jianliu
    Wang Huilan
    Wei Lihui
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 836 - 841
  • [38] Antigen Processing and MHC-II Presentation by Dermal and Tumor-Infiltrating Dendritic Cells
    Gerner, Michael Y.
    Mescher, Matthew F.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (05): : 2726 - 2737
  • [39] Clinical significance of tumor-infiltrating conventional and plasmacytoid dendritic cells in pancreatic ductal adenocarcinoma
    Plesca, I.
    Benesova, I.
    Beer, C.
    Sommer, U.
    Mueller, L.
    Wehner, R.
    Heiduk, M.
    Aust, D.
    Baretton, G.
    Bachmann, M. P.
    Feldmann, A.
    Weitz, J.
    Seifert, L.
    Seifert, A. M.
    Schmitz, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 65 - 65
  • [40] Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
    Plesca, Ioana
    Benesova, Iva
    Beer, Carolin
    Sommer, Ulrich
    Mueller, Luise
    Wehner, Rebekka
    Heiduk, Max
    Aust, Daniela
    Baretton, Gustavo
    Bachmann, Michael P.
    Feldmann, Anja
    Weitz, Juergen
    Seifert, Lena
    Seifert, Adrian M.
    Schmitz, Marc
    CANCERS, 2022, 14 (05)